Nayla Chaijale, Ph.D. - Publications
Affiliations: | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
neurobiology of eatingYear | Citation | Score | |||
---|---|---|---|---|---|
2024 | Hauser RA, Barkay H, Fernandez HH, Jimenez-Shahed J, Factor SA, Gross N, Marinelli L, Gordon MF, Barash S, Finkbeiner S, Chaijale N, Anderson KE. Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study. Journal of Clinical Psychopharmacology. 44: 386-396. PMID 38901008 DOI: 10.1097/JCP.0000000000001885 | 0.309 | |||
2013 | Chaijale NN, Aloyo VJ, Simansky KJ. The stereoisomer (+)-naloxone potentiates G-protein coupling and feeding associated with stimulation of mu opioid receptors in the parabrachial nucleus. Journal of Psychopharmacology (Oxford, England). 27: 302-11. PMID 23348755 DOI: 10.1177/0269881112472561 | 0.499 | |||
2013 | Valentino RJ, Chaijale N, Snyder K, Wang WW, Curtis A. The Locus Coeruleus, Stress, Opioids and Behavioral Flexibility Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 160. DOI: 10.1016/B978-0-12-800044-1.00142-2 | 0.367 | |||
2008 | Chaijale NN, Aloyo VJ, Simansky KJ. A naloxonazine sensitive (mu1 receptor) mechanism in the parabrachial nucleus modulates eating. Brain Research. 1240: 111-8. PMID 18805404 DOI: 10.1016/J.Brainres.2008.08.066 | 0.499 | |||
2006 | Cucchiaro G, Chaijale N, Commons KG. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine. Neuropharmacology. 50: 769-76. PMID 16460769 DOI: 10.1016/J.Neuropharm.2005.11.026 | 0.427 | |||
2005 | Cucchiaro G, Chaijale N, Commons KG. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine. The Journal of Pharmacology and Experimental Therapeutics. 313: 389-94. PMID 15608080 DOI: 10.1124/Jpet.104.079368 | 0.444 | |||
Show low-probability matches. |